Fernando Fervenza, MD
Enriched profileProfessor of Medicine; Section Head, Parenchymal Renal Division · Mayo Clinic
Fernando Fervenza is Professor of Medicine; Section Head, Parenchymal Renal Division at Mayo Clinic. OpenAlex indexes 591 publications with 39,885 citations (h-index 97); ClinicalTrials.gov lists 16 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Nephrology profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 15 Oct 2026
Fernando C. Fervenza, MD, is Professor of Medicine at Mayo Clinic (Mayo Clinic College of Medicine and Science), Rochester, Minnesota. The public record shows 591 publications with 39,885 citations (h-index 97), centered on Renal Diseases and Glomerulopathies, Vasculitis and related conditions, Amyloidosis: Diagnosis, Treatment, Outcomes. It also documents an investigator role on 16 registered clinical trials, industry payments reported by 16 companies, 1 NIH-funded awards (2004–2005).
- Most recent indexed publication: 2026 · Clinical kidney journal
- Top research focus: Renal Diseases and Glomerulopathies
- 16 registered trials on ClinicalTrials.gov
- Open Payments reporting from 16 companies
Generated from the cited public record · current as of 15 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 35 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 324.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 15 Oct 2026
Listed as an investigator on 16 registered studies on ClinicalTrials.gov. The most recent:
- Avacopan in Crescentic Immunoglobulin A Nephropathy (IgAN)
Sponsor: Mayo Clinic
- Obinutuzumab in Treatment of Fibrillary Glomerulonephritis
Sponsor: Mayo Clinic
Industry payments
Updated 15 Oct 2026
16 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Travere Therapeutics, Inc.Program year20259 payments
- VERTEX PHARMACEUTICALS INCORPORATEDProgram year20257 payments
- Alexion Pharmaceuticals, Inc.Program year20254 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
78%Loop diuretic25.3%Furosemide50%Torsemide50%Part D<11 patientsAngiotensin receptor blocker (ARB)24.7%Losartan Potassium100%Part D≥14 patients+ 3 more classes in this area
Anti-infectives
15.4%Short-acting sulfonamides15.4%Sulfamethoxazole-Trimethoprim100%Part D≥13 patientsMetabolism & gastrointestinal
6.6%SGLT2 inhibitor6.6%Farxiga100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 15 Oct 2026
1 NIH research award on record, funded 2004–2005 per NIH RePORTER. The latest:
- Membranous Nephropathy Observational Cohort Study
University of Michigan at Ann Arbor
FY2013$987,136U54DK083912 - Membranous Nephropathy Observational Cohort Study
University of Michigan at Ann Arbor
FY2012$988,177U54DK083912 - Membranous Nephropathy Observational Cohort Study
University of Michigan at Ann Arbor
FY2011$989,186U54DK083912
Congress activity
Updated 15 Oct 2026
3 congress contributions (2020–2022) across ASH per OpenAlex. The most recent:
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 15 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Long-term eculizumab treatment failure in C3 glomerulonephritis: two case reports.
Clinical kidney journal
Article2026 - Finerenone with empagliflozin in CKD with diabetes (CONFIDENCE): only a blood pressure effect? Likely!
Nephrology, dialysis, transplantation
Article2026 - Obinutuzumab or Tacrolimus in Primary Membranous Nephropathy.
The New England journal of medicine
Article2026 - A case of adrenal insufficiency after initiation of targeted-release budesonide formulation (Nefecon) in a patient with IgA nephropathy.
Clinical kidney journal
Case Report2026 - Antiproteinuric effect of SGLT2 inhibitors in non-diabetic glomerulopathies is dependent on body mass index.
Nephrology, dialysis, transplantation
Article2026
Most-cited works
by citation count (OpenAlex)Network
Updated 15 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 15 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/fernando-fervenza-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - ResearchGate
researchgate.net/profile/Fernando-Fervenza
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗ - X / Twitter
x.com/fervenzafernan1
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com ↗
Mentions by others
where others cite or feature them- Other
asn-online.org/about/bio.aspx
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →asn-online.org ↗ - YouTube
youtube.com/watch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 15 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →asn-online.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →asn-online.org ↗
- M.D.
Pontificia Universidade Catolica do Rio Grande do Sul (PUCRS), Brazil
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →asn-online.org ↗ - D.Phil. (Ph.D.)
Oxford University, Jesus College
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →jesus.ox.ac.uk ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →asn-online.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →asn-online.org ↗
- Board Certified
Nephrology, American Board of Internal Medicine
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →asn-online.org ↗
Editorial & leadership roles
journal and society appointments- Section Editor
Glomerular Disease, UpToDate
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →asn-online.org ↗ - Associate Editor
Journal of the American Society of Nephrology (JASN)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →asn-online.org ↗ - Director
Nephrology Collaborative Group, Mayo Clinic
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →hubresearch.ca ↗ - Course director
"Selected Topics in Glomerular Diseases and Kidney Pathology" CME course, Mayo Clinic School of Continuous Professional Development
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ce.mayo.edu ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →alumniassociation.mayo.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pmc.ncbi.nlm.nih.gov ↗
- Laureate Award
Mayo Clinic
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pmc.ncbi.nlm.nih.gov ↗
Secondary affiliations
appointments beyond the home institution- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pmc.ncbi.nlm.nih.gov ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →renalandurologynews.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →asn-online.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →hubresearch.ca ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
S Rajkumar, MD
Mayo Clinic
Bradley Boeve, MD
Mayo Clinic
Victor Montori, MD
Mayo Clinic
Ayalew Tefferi, MD
Mayo Clinic
Kenneth Anderson, MD
Dana-Farber Cancer Institute
Paul Richardson, MD
Dana-Farber Cancer Institute
S Rajkumar, MD
Mayo Clinic
Meletios Dimopoulos, MD
National and Kapodistrian University of Athens